tiprankstipranks
Trending News
More News >
Neurogene (NGNE)
NASDAQ:NGNE
US Market

Compare Neurogene (NGNE) vs. Competitors

Compare
586 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Neurogene
$18.68
$289.35M
-4.22
-13.08%
5 Buy
0 Hold
0 Sell
Strong Buy
Silence Therapeutics
$5.80
$273.96M
-3.47
-8.52%
2 Buy
0 Hold
0 Sell
Moderate Buy
Atea Pharmaceuticals
$3.61
$282.04M
-2.03
8.08%
2 Buy
0 Hold
0 Sell
Moderate Buy
Elicio Therapeutics
$8.24
$144.11M
-2.43
45.33%
2 Buy
0 Hold
0 Sell
Moderate Buy
Vor Biopharma
$12.78
$280.02M
-0.03
-60.80%
6 Buy
1 Hold
0 Sell
Strong Buy
Tenaya Therapeutics
$1.33
$167.14M
-0.98
-45.63%
8 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
NGNE
Neurogene
18.68
-0.13
-0.69%
SLN
Silence Therapeutics
5.80
-0.10
-1.69%
AVIR
Atea Pharmaceuticals
3.61
0.41
12.81%
ELTX
Elicio Therapeutics
8.24
2.38
40.61%
VOR
Vor Biopharma
12.78
-14.62
-53.36%
TNYA
Tenaya Therapeutics
0.77
-0.73
-48.53%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts